Lamotrigine Tablet
Product Images NDC 71335-0830

7 FDA label images from Bryant Ranch Prepack · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 71335-0830). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (2d955155 686d 40cd 898e Df7d760247a5 740 1)

FDA Label Image

Image (2d955155 686d 40cd 898e Df7d760247a5 789 2)

Image (2d955155 686d 40cd 898e Df7d760247a5 789 2)
Lamotrigine tablets in various strengths and shapes: 25 mg white oblong with imprint U 111; 100 mg white triangular with imprint U 112; 150 mg white triangular with imprint U 113; and 200 mg light blue triangular with imprint U 114. All are oral dosage forms.*
FDA Label Image

Image (2d955155 686d 40cd 898e Df7d760247a5 789 3)

FDA Label Image

Molecular Structure (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 01)

Molecular Structure (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 01)
Chemical structure diagram of Lamotrigine showing atomic connectivity, including chlorine atoms and amino groups, represented in a skeletal formula format.*
FDA Label Image

Figure 1 (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 02)

Figure 1 (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 02)
A Kaplan-Meier failure probability plot comparing Lamotrigine and placebo over a period of approximately 100 weeks. The vertical axis shows failure probability in percentage, while the horizontal axis shows time in weeks. The plot includes censored data points marked with crosses.*
FDA Label Image

Figure 2 (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 03)

Figure 2 (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 03)
A Kaplan-Meier failure probability curve comparing Lamotrigine and placebo over approximately 75 weeks. The y-axis shows failure probability percentage, and the x-axis indicates time in weeks. The Lamotrigine curve demonstrates lower failure probability compared to placebo across the study duration, with censored data marked by plus signs.*
FDA Label Image

Label (Lbl713350830)

Label (Lbl713350830)
Label for Lamotrigine 200 mg oral tablets packaged by Bryant Ranch Prepack. The label includes reference to Lamictal 200 mg tablets by Unichem Laboratories Ltd. It has storage instructions at 20°-25°C (68°-77°F) and warnings to keep out of reach of children. The label shows NDC 71335-0830 and indicates a quantity of 30 tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.